Contact
searchSearch
HMP Global

July 2013 - FRMC

Department
Foam Approved for Plaque Psoriasis of the Scalp
07/22/2013
The FDA approved Sorilux™ (calcipotriene) Foam as a topical treatment for adults with plaque psoriasis of the scalp.
The FDA approved Sorilux™ (calcipotriene) Foam as a topical treatment for adults with plaque psoriasis of the scalp.
The FDA approved Sorilux™...
07/22/2013
First Report Managed Care
Department
Oral Medication to Treat Myelofibrosis
07/22/2013
The FDA approved Jakafi® (ruxolitinib) in November 2011 to treat patients with myelofibrosis, a bone marrow disease. 
The FDA approved Jakafi® (ruxolitinib) in November 2011 to treat patients with myelofibrosis, a bone marrow disease. 
The FDA approved...
07/22/2013
First Report Managed Care
Department
Simeprevir Phase 3 Trial Results
07/22/2013
Tim Casey
Orlando—Treatment-naïve patients with hepatitis C who took 150 mg of simeprevir once daily in combination with peginterferon and ribavirin had a significantly better sustained virological response (SVR) rate compared with those taking...
Orlando—Treatment-naïve patients with hepatitis C who took 150 mg of simeprevir once daily in combination with peginterferon and ribavirin had a significantly better sustained virological response (SVR) rate compared with those taking...
Orlando—Treatment-naïve patients...
07/22/2013
First Report Managed Care
Conference Insider
Treatment Options for Ulcerative Colitis
07/22/2013
Tim Casey
Orlando—Clinicians have numerous options to treat patients with ulcerative colitis, a form of inflammatory bowel disease. The therapies include 5-amino-salacylic acid, thiopurine, and anti-tumor necrosis factor (TNF) agents such as...
Orlando—Clinicians have numerous options to treat patients with ulcerative colitis, a form of inflammatory bowel disease. The therapies include 5-amino-salacylic acid, thiopurine, and anti-tumor necrosis factor (TNF) agents such as...
Orlando—Clinicians have numerous...
07/22/2013
First Report Managed Care
Conference Insider
Linaclotide and Improved Abdominal and Bowel Symptoms
07/22/2013
Tim Casey
Orlando—An analysis of two phase 3 trials found that a higher percentage of patients who received linaclotide to treat abdominal and bowel symptoms had clinically meaningful improvement compared with a group receiving placebo. The clinically...
Orlando—An analysis of two phase 3 trials found that a higher percentage of patients who received linaclotide to treat abdominal and bowel symptoms had clinically meaningful improvement compared with a group receiving placebo. The clinically...
Orlando—An analysis of two phase...
07/22/2013
First Report Managed Care
Conference Insider
Extended Duration Thromboprophylaxis for Venous Thromboembolism
07/22/2013
Tim Casey
Orlando—Patients with venous thromboembolism (VTE) who took extended duration thromboprophylaxis had an incremental cost-effectiveness ratio of $8123 per quality-adjusted life year (QALY), according to a cost-effectiveness decision tree...
Orlando—Patients with venous thromboembolism (VTE) who took extended duration thromboprophylaxis had an incremental cost-effectiveness ratio of $8123 per quality-adjusted life year (QALY), according to a cost-effectiveness decision tree...
Orlando—Patients with venous...
07/22/2013
First Report Managed Care
Duration of Treatment with Linaclotide
07/22/2013
Tim Casey
Patients with irritable bowel syndrome whose symptoms improved after 4 weeks of treatment with linaclotide were highly likely to continue feeling better at week 12.
Patients with irritable bowel syndrome whose symptoms improved after 4 weeks of treatment with linaclotide were highly likely to continue feeling better at week 12.
Patients with irritable bowel...
07/22/2013
First Report Managed Care
Conference Insider
Readmission Rates and Gastrointestinal Surgeries
07/22/2013
Tim Casey
Orlando—After controlling for patient and operative factors, the authors in a study of patients undergoing major gastrointestinal surgeries found numerous factors were associated with an increased risk of 30-day unplanned readmissions.
Orlando—After controlling for patient and operative factors, the authors in a study of patients undergoing major gastrointestinal surgeries found numerous factors were associated with an increased risk of 30-day unplanned readmissions.
Orlando—After controlling for...
07/22/2013
First Report Managed Care
Conference Insider
Colorectal Cancer Screening and Colonoscopies
07/22/2013
Tim Casey
Orlando—As screening rates for colorectal cancer have increased in recent years, the incidence and death rates due to the disease have declined. Still, approximately 22 million people in the United States have never been screened, and the...
Orlando—As screening rates for colorectal cancer have increased in recent years, the incidence and death rates due to the disease have declined. Still, approximately 22 million people in the United States have never been screened, and the...
Orlando—As screening rates for...
07/22/2013
First Report Managed Care
Lifetime Burden of Inaccurate HER2 Testing
07/22/2013
Tori Socha
Chicago—Among the estimated 26,870 women who were diagnosed with breast cancer in 2012, 20% had tumors that overexpress the human epidermal growth factor 2 (HER2) gene, a marker of severity of disease that can influence therapy selection. All...
Chicago—Among the estimated 26,870 women who were diagnosed with breast cancer in 2012, 20% had tumors that overexpress the human epidermal growth factor 2 (HER2) gene, a marker of severity of disease that can influence therapy selection. All...
Chicago—Among the estimated...
07/22/2013
First Report Managed Care
News
Combination Therapy for Patients with Multiple Myeloma
07/22/2013
Tim Casey
Chicago—An analysis of a phase 3, randomized, multicenter, open-label study found that patients with pretreated relapsed and refractory multiple myeloma had an improvement in health-related quality of life if they received pomalidomide plus...
Chicago—An analysis of a phase 3, randomized, multicenter, open-label study found that patients with pretreated relapsed and refractory multiple myeloma had an improvement in health-related quality of life if they received pomalidomide plus...
Chicago—An analysis of a phase...
07/22/2013
First Report Managed Care
Breakthrough Pain in Cancer Patients
07/22/2013
Tim Casey
Patients with cancer who had breakthrough pain were statistically significantly more likely to have daily functioning problems compared with cancer patients who are pain-free, according to a database analysis of commercially-insured health...
Patients with cancer who had breakthrough pain were statistically significantly more likely to have daily functioning problems compared with cancer patients who are pain-free, according to a database analysis of commercially-insured health...
Patients with cancer who had...
07/22/2013
First Report Managed Care
BMN 673 for Breast Cancer and Ovarian Cancer
07/22/2013
Tim Casey
The initial study in humans of the investigational agent BMN 673 found that the oral drug has substantial anti-tumor activity in deleterious germline BRCA ovarian and breast cancer, according to a phase 1/2 trial.
The initial study in humans of the investigational agent BMN 673 found that the oral drug has substantial anti-tumor activity in deleterious germline BRCA ovarian and breast cancer, according to a phase 1/2 trial.
The initial study in humans of...
07/22/2013
First Report Managed Care
Bevacizumab plus Chemotherapy to Treat Cervical Cancer
07/22/2013
Tim Casey
Patients with recurrent and metastatic cervical cancer who received bevacizumab with their chemotherapy regimens had statistically significant improvement in overall survival compared with those taking chemotherapy alone. 
Patients with recurrent and metastatic cervical cancer who received bevacizumab with their chemotherapy regimens had statistically significant improvement in overall survival compared with those taking chemotherapy alone. 
Patients with recurrent and...
07/22/2013
First Report Managed Care
Ipilimumab plus Sargramostin for Metastatic Melanoma
07/22/2013
Tim Casey
Chicago—After a year of treatment, 68.9% of patients with metastatic melanoma who took ipilimumab plus sargramostin were alive compared with 52.9% of patients who received ipilimumab alone, according to a multicenter, randomized, phase 2...
Chicago—After a year of treatment, 68.9% of patients with metastatic melanoma who took ipilimumab plus sargramostin were alive compared with 52.9% of patients who received ipilimumab alone, according to a multicenter, randomized, phase 2...
Chicago—After a year of...
07/22/2013
First Report Managed Care
Conference Insider
Sorafenib to Treat Patients with Radioactive Iodine-Refractory Differentiated Thyroid Cancer
07/22/2013
Tim Casey
Chicago—An international, multicenter, double-blind, randomized, phase 3 trial found that patients with radioactive iodine-refractory differentiated thyroid cancer who took sorafenib had a significant improvement in progression-free survival...
Chicago—An international, multicenter, double-blind, randomized, phase 3 trial found that patients with radioactive iodine-refractory differentiated thyroid cancer who took sorafenib had a significant improvement in progression-free survival...
Chicago—An international,...
07/22/2013
First Report Managed Care
Pazopanib Improves Progression-Free Survival for Advanced Ovarian Cancer
07/22/2013
Tim Casey
Patients with advanced ovarian cancer who took pazopanib daily after initial treatment with surgery and chemotherapy had significantly longer progression-free survival compared with those who received placebo. 
Patients with advanced ovarian cancer who took pazopanib daily after initial treatment with surgery and chemotherapy had significantly longer progression-free survival compared with those who received placebo. 
Patients with advanced ovarian...
07/22/2013
First Report Managed Care
Enzalutamide for Hormone-Naïve Prostate Cancer
07/22/2013
Tim Casey
  Chicago—Patients with hormone-naïve prostate cancer who took 160 mg of enzalutamide daily for 24 weeks had a median decrease in prostate-specific antigen (PSA) of 99.6%, according to a phase 2, open-label, single-arm study. In addition,...
  Chicago—Patients with hormone-naïve prostate cancer who took 160 mg of enzalutamide daily for 24 weeks had a median decrease in prostate-specific antigen (PSA) of 99.6%, according to a phase 2, open-label, single-arm study. In addition,...
  Chicago—Patients with...
07/22/2013
First Report Managed Care
News Connection
Inpatient Care Provider Communication with Outpatient Care Provider
07/22/2013
Tori Socha
There is a growing model of inpatient care that includes the use of hospitalists, which may be one of the factors exacerbating the already poor level of communication between inpatient and outpatient healthcare providers. The discontinuity of...
There is a growing model of inpatient care that includes the use of hospitalists, which may be one of the factors exacerbating the already poor level of communication between inpatient and outpatient healthcare providers. The discontinuity of...
There is a growing model of...
07/22/2013
First Report Managed Care
News Connection
Predicting Avoidable 30-Day Hospital Readmissions
07/22/2013
Tori Socha
A common costly component to overall healthcare costs is hospital readmission. The 30-day readmission rate in the United States is 18% according to recent studies, and the cost of readmissions among Medicare beneficiaries is an estimated $17...
A common costly component to overall healthcare costs is hospital readmission. The 30-day readmission rate in the United States is 18% according to recent studies, and the cost of readmissions among Medicare beneficiaries is an estimated $17...
A common costly component to...
07/22/2013
First Report Managed Care
Short-Term Glucocorticoid Therapy for COPD
07/22/2013
Tori Socha
Exacerbations of chronic obstructive pulmonary disease (COPD) are risk factors for disease progression. Patients with COPD who experience frequent acute exacerbations are at increased risk for death. In a study cohort in Switzerland, 23% to...
Exacerbations of chronic obstructive pulmonary disease (COPD) are risk factors for disease progression. Patients with COPD who experience frequent acute exacerbations are at increased risk for death. In a study cohort in Switzerland, 23% to...
Exacerbations of chronic...
07/22/2013
First Report Managed Care
Financial Burden of Dementia in the United States
07/22/2013
Tori Socha
A large and growing population of Americans are being diagnosed with dementia, a chronic disease of aging characterized by progressive cognitive decline that interferes with independent functioning. In January 2011, President Barack Obama...
A large and growing population of Americans are being diagnosed with dementia, a chronic disease of aging characterized by progressive cognitive decline that interferes with independent functioning. In January 2011, President Barack Obama...
A large and growing population...
07/22/2013
First Report Managed Care
News Connection
Patient Input in Medical Decision-Making Process
07/22/2013
Tori Socha
In the past 10 years, according to researchers, the concept of physicians informing and involving patients in medical decisions has begun to take hold, at least in policy circles. The American Medical Association has endorsed the concept of...
In the past 10 years, according to researchers, the concept of physicians informing and involving patients in medical decisions has begun to take hold, at least in policy circles. The American Medical Association has endorsed the concept of...
In the past 10 years, according...
07/22/2013
First Report Managed Care
Low-Dose CT versus Chest Radiography for Lung Cancer Screening
07/22/2013
Tori Socha
It is estimated that lung cancer, the largest single cause of cancer death in the world, will account for >100,000 deaths in the United States in 2013. The majority of patients with lung cancer have been smokers and half of the 94 million...
It is estimated that lung cancer, the largest single cause of cancer death in the world, will account for >100,000 deaths in the United States in 2013. The majority of patients with lung cancer have been smokers and half of the 94 million...
It is estimated that lung...
07/22/2013
First Report Managed Care
News Connection
Prognostic Expectations of Patients with End-Stage Renal Disease
07/22/2013
Tori Socha
Approximately 400,000 Americans undergo long-term dialysis and patients with end-stage renal disease in the United States have a 20% to 25% 1-year mortality rate, which is comparable to many types of cancer. Being given an accurate estimate...
Approximately 400,000 Americans undergo long-term dialysis and patients with end-stage renal disease in the United States have a 20% to 25% 1-year mortality rate, which is comparable to many types of cancer. Being given an accurate estimate...
Approximately 400,000 Americans...
07/22/2013
First Report Managed Care
Nonbenzodiazepine Hypnotic Drugs and Fracture Risk
07/22/2013
Tori Socha
Since 2006, Medicare Part D has had a policy that excludes benzodiazepines from mandatory drug coverage. The restriction had increased the use of nonbenzodiazepine sleep medications (zolpidem tartrate) to treat insomnia in nursing homes in...
Since 2006, Medicare Part D has had a policy that excludes benzodiazepines from mandatory drug coverage. The restriction had increased the use of nonbenzodiazepine sleep medications (zolpidem tartrate) to treat insomnia in nursing homes in...
Since 2006, Medicare Part D has...
07/22/2013
First Report Managed Care
Hepatitis C Virus Infection Testing
07/22/2013
Tori Socha
According to the Centers for Disease Control and Prevention (CDC), there are an estimated 3.2 million people in the United States living with hepatitis C virus (HCV) infection and new infections continue to occur. Once infected with HCV,...
According to the Centers for Disease Control and Prevention (CDC), there are an estimated 3.2 million people in the United States living with hepatitis C virus (HCV) infection and new infections continue to occur. Once infected with HCV,...
According to the Centers for...
07/22/2013
First Report Managed Care
News Connection
Reaching Goals of Diabetes Care in the United States
07/22/2013
Tori Socha
Diabetes mellitus has been diagnosed in an estimated 18.8 million adults in the United States. Patients with diabetes are at increased risk for disabling and life-threatening complications from microvascular diseases (affecting the kidneys,...
Diabetes mellitus has been diagnosed in an estimated 18.8 million adults in the United States. Patients with diabetes are at increased risk for disabling and life-threatening complications from microvascular diseases (affecting the kidneys,...
Diabetes mellitus has been...
07/22/2013
First Report Managed Care
News Connection
Reducing Catheter-Associated Urinary Tract Infections
07/22/2013
Tori Socha
Decreasing preventable hospital-acquired conditions by 40% by the end of 2013 is a goal established by the US Department of Health & Human Services. The initiative to reduce those conditions included a focus on healthcare-associated...
Decreasing preventable hospital-acquired conditions by 40% by the end of 2013 is a goal established by the US Department of Health & Human Services. The initiative to reduce those conditions included a focus on healthcare-associated...
Decreasing preventable...
07/22/2013
First Report Managed Care
News Connection
Time to Treatment and Survival in Young Women with Breast Cancer
07/22/2013
Tori Socha
Researchers recently conducted a study to examine the impact of treatment delay time as well as race/ethnicity, socioeconomic status, insurance status, cancer stage, and age on survival from breast cancer among adolescent and young...
Researchers recently conducted a study to examine the impact of treatment delay time as well as race/ethnicity, socioeconomic status, insurance status, cancer stage, and age on survival from breast cancer among adolescent and young...
Researchers recently conducted a...
07/22/2013
First Report Managed Care
Two Doses of HPV Vaccine in Girls versus 3 Doses in Young Women
07/22/2013
Tori Socha
Worldwide, cervical cancer is the second most common cause of cancer morbidity and mortality in women. Human papillomavirus (HPV) is a necessary cause for the development of cervical cancer; HPV genotypes 16 and 18 account for approximately...
Worldwide, cervical cancer is the second most common cause of cancer morbidity and mortality in women. Human papillomavirus (HPV) is a necessary cause for the development of cervical cancer; HPV genotypes 16 and 18 account for approximately...
Worldwide, cervical cancer is...
07/22/2013
First Report Managed Care
News Connection
Social Network to Monitor Hypoglycemia
07/22/2013
Tori Socha
According to researchers, “Hypoglycemia is a serious sequela of diabetes treatment not tracked by formal health surveillance. Associated harms span vehicle crashes and injuries, missed work, debilitating worry, medical complications, and...
According to researchers, “Hypoglycemia is a serious sequela of diabetes treatment not tracked by formal health surveillance. Associated harms span vehicle crashes and injuries, missed work, debilitating worry, medical complications, and...
According to researchers,...
07/22/2013
First Report Managed Care
Bleeding and In-Hospital Mortality after PCI
07/22/2013
Tori Socha
The most common noncardiac complication of percutaneous coronary intervention (PCI) is bleeding. Bleeding following PCI is associated with short- and long-term death, nonfatal myocardial infarction, stroke, blood transfusion, prolonged...
The most common noncardiac complication of percutaneous coronary intervention (PCI) is bleeding. Bleeding following PCI is associated with short- and long-term death, nonfatal myocardial infarction, stroke, blood transfusion, prolonged...
The most common noncardiac...
07/22/2013
First Report Managed Care
Liver Disease State and Antiretroviral Therapy in Patients with HIV/HCV
07/22/2013
Tori Socha
According to researchers, individuals infected with HIV often experience hepatitis C virus (HCV) coinfection. Among patients treated with effective HIV antiretroviral therapy (ART), the presence of HCV infection has been associated with an...
According to researchers, individuals infected with HIV often experience hepatitis C virus (HCV) coinfection. Among patients treated with effective HIV antiretroviral therapy (ART), the presence of HCV infection has been associated with an...
According to researchers,...
07/22/2013
First Report Managed Care
News Connection
Strategies for Identifying Diabetes in Adolescents
07/22/2013
Jill Sederstorm
A study investigating the cost effectiveness of diabetes mellitus screening strategies for children found that the cost per case was extremely high for all screening options; however, researchers noted that screening could be more cost...
A study investigating the cost effectiveness of diabetes mellitus screening strategies for children found that the cost per case was extremely high for all screening options; however, researchers noted that screening could be more cost...
A study investigating the cost...
07/22/2013
First Report Managed Care
Enoxaparin in Patients with Moderate Renal Impairment
07/22/2013
Kevin L. Carter
Enoxaparin sodium, a heparin with a low molecular weight, allows for simplified dosing without the need for vigilant monitoring through laboratory tests.
Enoxaparin sodium, a heparin with a low molecular weight, allows for simplified dosing without the need for vigilant monitoring through laboratory tests.
Enoxaparin sodium, a heparin...
07/22/2013
First Report Managed Care
Cancer and Mortality in a Psychiatric Population
07/22/2013
Tori Socha
The incidence rate of cancer in patients with mental illness is similar to that in patients without mental illness; however, overall mortality in cancer patients with mental illness is higher than in the general population. The rate of...
The incidence rate of cancer in patients with mental illness is similar to that in patients without mental illness; however, overall mortality in cancer patients with mental illness is higher than in the general population. The rate of...
The incidence rate of cancer in...
07/22/2013
First Report Managed Care
News Connection
Glucose Control with an Artificial-Pancreas System
07/22/2013
Tori Socha
Standard treatment for tight blood glucose control in patients with type 1 diabetes is intensive insulin therapy designed to prevent long-term complications. The use of insulin pumps, glucose sensors, or a combination of the 2 devices has...
Standard treatment for tight blood glucose control in patients with type 1 diabetes is intensive insulin therapy designed to prevent long-term complications. The use of insulin pumps, glucose sensors, or a combination of the 2 devices has...
Standard treatment for tight...
07/22/2013
First Report Managed Care
News Connection
Physicians and Nurse Practitioners Respond to National Survey
07/22/2013
Tori Socha
There is a shortage of primary care physicians in the United States, a situation made more critical in the face of an aging population and an increase in the incidence and prevalence of chronic illnesses. When the provisions of the Patient...
There is a shortage of primary care physicians in the United States, a situation made more critical in the face of an aging population and an increase in the incidence and prevalence of chronic illnesses. When the provisions of the Patient...
There is a shortage of primary...
07/22/2013
First Report Managed Care
News Connection
Supreme Court Rules on Pay-for-Delay Settlements
07/22/2013
Tim Casey
As drugs become close to losing patent protection, brand manufacturers typically want to extend the exclusivity of their drugs for as long as possible. They spend billions of dollars to develop and market the products, which can generate...
As drugs become close to losing patent protection, brand manufacturers typically want to extend the exclusivity of their drugs for as long as possible. They spend billions of dollars to develop and market the products, which can generate...
As drugs become close to losing...
07/22/2013
First Report Managed Care
News Connection
PCORI Established to Fund Patient-Centered Research
07/22/2013
Tim Casey
Since the mid-1990s, Jonathan Tobin, PhD, and his colleagues have conducted research studies focused on increasing cancer screening among minority women. Three times, they received funding from the National Cancer Institute to assess patient...
Since the mid-1990s, Jonathan Tobin, PhD, and his colleagues have conducted research studies focused on increasing cancer screening among minority women. Three times, they received funding from the National Cancer Institute to assess patient...
Since the mid-1990s, Jonathan...
07/22/2013
First Report Managed Care

Behind the Bill

Behind the Bill
The Senate’s $3 Trillion Deal. Tax Relief Now, Medicaid Coverage Loss Later?
07/02/2025
Katie Hayes, MJ
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After...
07/02/2025
First Report Managed Care
Behind the Bill
When a Cap Isn’t Just a Cap: How a Provider Tax Proposal Could Reshape Medicaid Financing
06/25/2025
Katie Hayes, MJ
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most...
06/25/2025
First Report Managed Care
Behind the Bill
Rewriting the Safety Net? Inside the Senate’s Changes to Medicaid and the ACA
06/18/2025
Katie Hayes, MJ
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve...
06/18/2025
First Report Managed Care
Behind the Bill
How States Might Respond to the One Big Beautiful Bill Act
06/11/2025
Katie Hayes, MJ
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill...
06/11/2025
First Report Managed Care
Behind the Bill
Is the Affordable Care Act on the Chopping Block? What the One Big Beautiful Bill Act Tells Us.
06/04/2025
Katie Hayes, MJ
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of...
06/04/2025
First Report Managed Care
Behind the Bill
From House to Senate: The Journey of Cutting Medicaid
05/28/2025
Katie Hayes, MJ
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of...
05/28/2025
First Report Managed Care
Behind the Bill
Eligibility, Paperwork, and Penalties: The Not-So-Hidden Costs of Medicaid ‘Reform’
05/21/2025
Katie Hayes, MJ
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week...
05/21/2025
First Report Managed Care
Behind the Bill
A Busy Week in Drug Pricing Policy: Aligning US Drug Prices With Global Standards?
05/14/2025
Katie Hayes, MJ
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for...
05/14/2025
First Report Managed Care
BEHIND THE BILL
When Agencies Lose Power: How 3 Seismic Shifts are Transforming Pharmaceutical Regulation
05/07/2025
Katie Hayes, MJ
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
In the span of just 9 months,...
05/07/2025
First Report Managed Care
Behind the Bill
The Medicare Paradox, Part 3: Strategic Trade Doesn’t Have to be a Zero-Sum Game
05/07/2025
Katie Hayes, MJ
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
Over the past 2 weeks, I’ve...
05/07/2025
First Report Managed Care

Trending Articles

News
Task Force Publishes Target-To-Treat Guidance for GCA and PMR
03/12/2024
Jolynn Tumolo
An international task force recently published the first target-to-treat (T2T) recommendations for patients with giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) in the Annals of the Rheumatic Diseases.
An international task force recently published the first target-to-treat (T2T) recommendations for patients with giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) in the Annals of the Rheumatic Diseases.
An international task force...
03/12/2024
First Report Managed Care
Asembia: More Than an Annual Conference
04/15/2024

Emry Lloyd

Emry Lloyd
Asembia, established in 2005, pioneered the recognition and promotion of specialty pharmacies, focusing on becoming a leader in the specialty pharmacy group purchasing organization sector. Offering scalable solutions, including prescription...
Asembia, established in 2005, pioneered the recognition and promotion of specialty pharmacies, focusing on becoming a leader in the specialty pharmacy group purchasing organization sector. Offering scalable solutions, including prescription...
Asembia, established in 2005,...
04/15/2024
First Report Managed Care
Conference Coverage
Addressing Suicidal Ideation in Persons With Multiple Sclerosis: Developing a Predictive Nomogram
05/22/2024
Hannah Musick
New research explored the development of a predictive nomogram to identify persons with multiple sclerosis at higher risk of suicidal ideation, emphasizing the importance of behavioral risk factors in this vulnerable population.
New research explored the development of a predictive nomogram to identify persons with multiple sclerosis at higher risk of suicidal ideation, emphasizing the importance of behavioral risk factors in this vulnerable population.
New research explored the...
05/22/2024
First Report Managed Care
News
Johnson & Johnson Expands Use of Prezcobix for Pediatric Patients in the US
06/21/2024
Hannah Musick
Johnson & Johnson aims to expand use of its HIV-1 therapy, Prezcobix, for younger patients in the US, potentially paving the way for improved treatment options for pediatric patients with the virus.
Johnson & Johnson aims to expand use of its HIV-1 therapy, Prezcobix, for younger patients in the US, potentially paving the way for improved treatment options for pediatric patients with the virus.
Johnson & Johnson aims to expand...
06/21/2024
First Report Managed Care
Brian Esterly Headshot
Interview
Insights on the 2024 Medicare Physician Fee Schedule: Implications and Opportunities for Virtual Care Management Services
07/26/2024
The current Medicare Physician Fee Schedule brought many significant changes to increase access to much needed virtual care management (VCM) services to underserved populations. Learn more about the potential implications of these fee...
The current Medicare Physician Fee Schedule brought many significant changes to increase access to much needed virtual care management (VCM) services to underserved populations. Learn more about the potential implications of these fee...
The current Medicare Physician...
07/26/2024
First Report Managed Care

July 2013 Volume 10 Issue 7

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use